HealthEquity, Inc. (NASDAQ:HQY - Get Free Report) crossed below its 50-day moving average during trading on Friday. The stock has a 50-day moving average of $96.54 and traded as low as $94.37. HealthEquity shares last traded at $94.74, with a volume of 741,341 shares changing hands.
Analyst Ratings Changes
A number of analysts have recently weighed in on HQY shares. Citigroup reiterated a "market outperform" rating on shares of HealthEquity in a research report on Friday, August 28th. Telsey Advisory Group set a $111.00 target price on HealthEquity in a report on Friday, August 28th. Wall Street Zen upgraded HealthEquity from a "hold" rating to a "buy" rating in a research report on Saturday, October 10th. BMO Capital Markets boosted their price target on HealthEquity from $105.00 to $125.00 and gave the company an "outperform" rating in a research note on Wednesday, October 21st. Finally, Barclays boosted their price target on HealthEquity from $110.00 to $115.00 and gave the company an "overweight" rating in a research note on Friday, September 18th. One research analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and one has given a Sell rating to the company. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $113.53.
Get Our Latest Stock Report on HealthEquity
HealthEquity Trading Down 2.7%
The firm has a market capitalization of $7.84 billion, a price-to-earnings ratio of 34.20, a P/E/G ratio of 1.65 and a beta of 0.22. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.99 and a quick ratio of 2.99. The firm's 50-day simple moving average is $96.54 and its 200 day simple moving average is $90.35.
HealthEquity (NASDAQ:HQY - Get Free Report) last issued its earnings results on Thursday, August 27th. The company reported $1.24 earnings per share for the quarter, beating analysts' consensus estimates of $1.19 by $0.05. HealthEquity had a return on equity of 15.33% and a net margin of 17.36%. The firm had revenue of $350.73 million for the quarter, compared to the consensus estimate of $349.22 million. The company's quarterly revenue was up 95.5% on a year-over-year basis. HealthEquity has set its FY 2027 guidance at 4.660-4.730 EPS. Equities analysts expect that HealthEquity, Inc. will post 3.94 earnings per share for the current year.
Insiders Place Their Bets
In other HealthEquity news, Director Adrian Dillon sold 7,632 shares of HealthEquity stock in a transaction dated Tuesday, August 25th. The stock was sold at an average price of $104.61, for a total value of $798,383.52. Following the transaction, the director owned 62,395 shares in the company, valued at $6,527,140.95. The trade was a 10.90% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 1.60% of the stock is owned by company insiders.
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently made changes to their positions in HQY. American Century Companies Inc. grew its holdings in shares of HealthEquity by 12.6% during the 3rd quarter. American Century Companies Inc. now owns 855,483 shares of the company's stock valued at $75,676,000 after purchasing an additional 95,505 shares during the last quarter. Cim Investment Management Inc. increased its position in HealthEquity by 61.9% during the 3rd quarter. Cim Investment Management Inc. now owns 6,486 shares of the company's stock worth $574,000 after purchasing an additional 2,479 shares in the last quarter. Algert Global LLC bought a new position in HealthEquity in the 3rd quarter valued at approximately $1,047,000. Castleark Management LLC lifted its stake in HealthEquity by 1.0% in the 3rd quarter. Castleark Management LLC now owns 129,080 shares of the company's stock valued at $11,418,000 after purchasing an additional 1,310 shares during the last quarter. Finally, Allworth Financial LP lifted its stake in HealthEquity by 17.3% in the 3rd quarter. Allworth Financial LP now owns 2,890 shares of the company's stock valued at $256,000 after purchasing an additional 426 shares during the last quarter. Institutional investors own 99.55% of the company's stock.
HealthEquity Company Profile
(
Get Free Report)
HealthEquity, Inc. provides technology and services for health savings accounts (HSAs) and other consumer-directed benefits. Its platform supports employers, health plans, benefits advisers and individuals in managing health-related accounts and benefits. Alongside HSAs, the company administers flexible spending accounts, health reimbursement arrangements, commuter benefits and other workplace benefit programs. Its services include account administration, payment tools, customer support and investment options for eligible HSA funds.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider HealthEquity, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HealthEquity wasn't on the list.
While HealthEquity currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.